drugset / Trial / NCT06084962
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
Clinical Trial for the safety and efficacy of DeepTag-GPRC5D targeted CAR-T cells therapy for refractory/relapsed multiple myeloma
Timeline
- Start
- 2023-10-20
- Primary completion
- 2026-10-20
- Completion
- 2026-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DeepTag-GPRC5D Targeted CAR T-cells | Unknown | — | Intravenous |